You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAD001

Showing 1 - 25 of 470
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial in Morristown, Houston (Letrozole, RAD001 (Everolimus))

Active, not recruiting
Has Results
  • Endometrial Cancer
  • Morristown, New Jersey
  • +1 more
Nov 16, 2022

Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

Completed
Has Results
  • Breast Cancer
  • Neoplasm Metastasis
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 30, 2022

Neurofibromatosis Type 2, Neuroma, Acoustic Trial in Los Angeles (RAD001, everolimus)

Active, not recruiting
  • Neurofibromatosis Type 2
  • Neuroma, Acoustic
  • RAD001, everolimus
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Boston (RAD001, PKC412)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Boston, Massachusetts
  • +2 more
Mar 28, 2022

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
Has Results
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome Trial in Palo Alto, Boston, Cleveland (RAD001, Placebo)

Completed
  • PTEN Gene Mutation
  • PTEN Hamartoma Tumor Syndrome
  • RAD001
  • Placebo
  • Palo Alto, California
  • +2 more
Feb 7, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Endometrial Cancer Trial in Pensacola, Voorhees, Houston (Metformin, Letrozole, Everolimus)

Active, not recruiting
  • Endometrial Cancer
  • Pensacola, Florida
  • +5 more
Feb 9, 2022

Thyroid Cancer Trial in Boston, New York, Houston (RAD001)

Completed
Has Results
  • Thyroid Cancer
  • RAD001
  • Boston, Massachusetts
  • +3 more
Oct 1, 2021

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Renal Angiomyolipoma Trial (Everolimus)

Not yet recruiting
  • Renal Angiomyolipoma
  • (no location specified)
Aug 15, 2022

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)

Suspended
  • Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021

Metastatic Melanoma Trial in United States (Bevacizumab, Everolimus)

Completed
Has Results
  • Metastatic Melanoma
  • Fort Myers, Florida
  • +14 more
Nov 22, 2021

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting
  • HER2+ Breast Cancer
  • Xi'an, Shaanxi, China
  • +1 more
Jun 20, 2022

Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast Cancer Trial in Israel (Everolimus,

Completed
Has Results
  • Postmenopausal Women
  • +2 more
  • Jerusalem, Israel
  • +6 more
Mar 25, 2021